 | • レポートコード：MRC2-11QY11724 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、130ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は変形性関節症鎮痛薬のグローバル市場について調査・分析したレポートです。種類別（経口、注射、外部）市場規模、用途別（医療、パーソナルケア）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別変形性関節症鎮痛薬の競争状況、市場シェア ・世界の変形性関節症鎮痛薬市場：種類別市場規模 2015年-2020年（経口、注射、外部） ・世界の変形性関節症鎮痛薬市場：種類別市場規模予測 2021年-2026年（経口、注射、外部） ・世界の変形性関節症鎮痛薬市場：用途別市場規模 2015年-2020年（医療、パーソナルケア） ・世界の変形性関節症鎮痛薬市場：用途別市場規模予測 2021年-2026年（医療、パーソナルケア） ・北米の変形性関節症鎮痛薬市場分析：米国、カナダ ・ヨーロッパの変形性関節症鎮痛薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの変形性関節症鎮痛薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の変形性関節症鎮痛薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの変形性関節症鎮痛薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Johnson & Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Geographically, the global Drugs for Osteoarthritis Pain market has been segmented into North America, Europe, China, Japan, Rest of Asia (RoA), and Rest of World (RoW). The North America held the largest share in the global market, its revenue of global market exceeds 38% in 2017. The next is Europe.
Market Analysis and Insights: Global Drugs for Osteoarthritis Pain Market
The global Drugs for Osteoarthritis Pain market size is projected to reach US$ 12370 million by 2026, from US$ 8870.8 million in 2020, at a CAGR of 5.7% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Drugs for Osteoarthritis Pain market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Drugs for Osteoarthritis Pain market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Drugs for Osteoarthritis Pain market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Drugs for Osteoarthritis Pain market.
Global Drugs for Osteoarthritis Pain Scope and Market Size
Drugs for Osteoarthritis Pain market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drugs for Osteoarthritis Pain market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Market segment by Type, the product can be split into
Oral
Injection
External
Market segment by Application, split into
Medical Care
Personal Care
Based on regional and country-level analysis, the Drugs for Osteoarthritis Pain market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Drugs for Osteoarthritis Pain market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Drugs for Osteoarthritis Pain Market Share by Application: 2020 VS 2026
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Osteoarthritis Pain Market Perspective (2015-2026)
2.2 Global Drugs for Osteoarthritis Pain Growth Trends by Regions
2.2.1 Drugs for Osteoarthritis Pain Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Drugs for Osteoarthritis Pain Historic Market Share by Regions (2015-2020)
2.2.3 Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Osteoarthritis Pain Players by Market Size
3.1.1 Global Top Drugs for Osteoarthritis Pain Players by Revenue (2015-2020)
3.1.2 Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2015-2020)
3.2 Global Drugs for Osteoarthritis Pain Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Drugs for Osteoarthritis Pain Revenue
3.4 Global Drugs for Osteoarthritis Pain Market Concentration Ratio
3.4.1 Global Drugs for Osteoarthritis Pain Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Osteoarthritis Pain Revenue in 2019
3.5 Key Players Drugs for Osteoarthritis Pain Area Served
3.6 Key Players Drugs for Osteoarthritis Pain Product Solution and Service
3.7 Date of Enter into Drugs for Osteoarthritis Pain Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Osteoarthritis Pain Breakdown Data by Type (2015-2026)
4.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Type (2015-2020)
4.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Type (2021-2026)
5 Drugs for Osteoarthritis Pain Breakdown Data by Application (2015-2026)
5.1 Global Drugs for Osteoarthritis Pain Historic Market Size by Application (2015-2020)
5.2 Global Drugs for Osteoarthritis Pain Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Drugs for Osteoarthritis Pain Market Size (2015-2026)
6.2 North America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020)
6.3 North America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020)
6.4 North America Drugs for Osteoarthritis Pain Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Drugs for Osteoarthritis Pain Market Size (2015-2026)
7.2 Europe Drugs for Osteoarthritis Pain Market Size by Type (2015-2020)
7.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2015-2020)
7.4 Europe Drugs for Osteoarthritis Pain Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Drugs for Osteoarthritis Pain Market Size (2015-2026)
8.2 China Drugs for Osteoarthritis Pain Market Size by Type (2015-2020)
8.3 China Drugs for Osteoarthritis Pain Market Size by Application (2015-2020)
8.4 China Drugs for Osteoarthritis Pain Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Drugs for Osteoarthritis Pain Market Size (2015-2026)
9.2 Japan Drugs for Osteoarthritis Pain Market Size by Type (2015-2020)
9.3 Japan Drugs for Osteoarthritis Pain Market Size by Application (2015-2020)
9.4 Japan Drugs for Osteoarthritis Pain Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Drugs for Osteoarthritis Pain Market Size (2015-2026)
10.2 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2015-2020)
10.3 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2015-2020)
10.4 Southeast Asia Drugs for Osteoarthritis Pain Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Drugs for Osteoarthritis Pain Introduction
11.1.4 Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020))
11.1.5 Pfizer Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Drugs for Osteoarthritis Pain Introduction
11.2.4 Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.2.5 Johnson & Johnson Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Drugs for Osteoarthritis Pain Introduction
11.3.4 GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.3.5 GlaxoSmithKline Recent Development
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Drugs for Osteoarthritis Pain Introduction
11.4.4 Bayer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.4.5 Bayer Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Drugs for Osteoarthritis Pain Introduction
11.5.4 Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.5.5 Eli Lilly Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Drugs for Osteoarthritis Pain Introduction
11.6.4 Novartis Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.6.5 Novartis Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Drugs for Osteoarthritis Pain Introduction
11.7.4 Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.7.5 Sanofi Recent Development
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Drugs for Osteoarthritis Pain Introduction
11.8.4 Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.8.5 Horizon Pharma Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Drugs for Osteoarthritis Pain Introduction
11.9.4 Abbott Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.9.5 Abbott Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Drugs for Osteoarthritis Pain Introduction
11.10.4 Mylan Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
11.10.5 Mylan Recent Development
11.11 Daiichi Sankyo
10.11.1 Daiichi Sankyo Company Details
10.11.2 Daiichi Sankyo Business Overview
10.11.3 Daiichi Sankyo Drugs for Osteoarthritis Pain Introduction
10.11.4 Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.11.5 Daiichi Sankyo Recent Development
11.12 TEVA
10.12.1 TEVA Company Details
10.12.2 TEVA Business Overview
10.12.3 TEVA Drugs for Osteoarthritis Pain Introduction
10.12.4 TEVA Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.12.5 TEVA Recent Development
11.13 Almatica Pharma
10.13.1 Almatica Pharma Company Details
10.13.2 Almatica Pharma Business Overview
10.13.3 Almatica Pharma Drugs for Osteoarthritis Pain Introduction
10.13.4 Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.13.5 Almatica Pharma Recent Development
11.14 Astellas Pharma
10.14.1 Astellas Pharma Company Details
10.14.2 Astellas Pharma Business Overview
10.14.3 Astellas Pharma Drugs for Osteoarthritis Pain Introduction
10.14.4 Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.14.5 Astellas Pharma Recent Development
11.15 Tide Pharmaceutical
10.15.1 Tide Pharmaceutical Company Details
10.15.2 Tide Pharmaceutical Business Overview
10.15.3 Tide Pharmaceutical Drugs for Osteoarthritis Pain Introduction
10.15.4 Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.15.5 Tide Pharmaceutical Recent Development
11.16 Iroko Pharmaceuticals
10.16.1 Iroko Pharmaceuticals Company Details
10.16.2 Iroko Pharmaceuticals Business Overview
10.16.3 Iroko Pharmaceuticals Drugs for Osteoarthritis Pain Introduction
10.16.4 Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.16.5 Iroko Pharmaceuticals Recent Development
11.17 Hengrui Pharmaceutical
10.17.1 Hengrui Pharmaceutical Company Details
10.17.2 Hengrui Pharmaceutical Business Overview
10.17.3 Hengrui Pharmaceutical Drugs for Osteoarthritis Pain Introduction
10.17.4 Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.17.5 Hengrui Pharmaceutical Recent Development
11.18 Abiogen Pharma
10.18.1 Abiogen Pharma Company Details
10.18.2 Abiogen Pharma Business Overview
10.18.3 Abiogen Pharma Drugs for Osteoarthritis Pain Introduction
10.18.4 Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020)
10.18.5 Abiogen Pharma Recent Development
12Analyst’s Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Drugs for Osteoarthritis Pain Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Oral
Table 4. Key Players of Injection
Table 5. Key Players of External
Table 6. Global Drugs for Osteoarthritis Pain Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Drugs for Osteoarthritis Pain Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Drugs for Osteoarthritis Pain Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Drugs for Osteoarthritis Pain Market Share by Regions (2015-2020)
Table 10. Global Drugs for Osteoarthritis Pain Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Drugs for Osteoarthritis Pain Market Share by Regions (2021-2026)
Table 12. Drugs for Osteoarthritis Pain Market Market Trends
Table 13. Drugs for Osteoarthritis Pain Market Drivers
Table 14. Drugs for Osteoarthritis Pain Market Challenges
Table 15. Drugs for Osteoarthritis Pain Market Restraints
Table 16. Global Drugs for Osteoarthritis Pain Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Drugs for Osteoarthritis Pain Market Share by Players (2015-2020)
Table 18. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2019)
Table 19. Global Drugs for Osteoarthritis Pain by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Drugs for Osteoarthritis Pain Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Drugs for Osteoarthritis Pain Market Size Share by Type (2015-2020)
Table 25. Global Drugs for Osteoarthritis Pain Revenue Market Share by Type (2021-2026)
Table 26. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2015-2020)
Table 27. Global Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Drugs for Osteoarthritis Pain Market Size Share by Application (2021-2026)
Table 29. North America Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Drugs for Osteoarthritis Pain Market Share by Type (2015-2020)
Table 31. North America Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Drugs for Osteoarthritis Pain Market Share by Application (2015-2020)
Table 33. North America Drugs for Osteoarthritis Pain Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Drugs for Osteoarthritis Pain Market Share by Country (2015-2020)
Table 35. Europe Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Drugs for Osteoarthritis Pain Market Share by Type (2015-2020)
Table 37. Europe Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Drugs for Osteoarthritis Pain Market Share by Application (2015-2020)
Table 39. Europe Drugs for Osteoarthritis Pain Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Drugs for Osteoarthritis Pain Market Share by Country (2015-2020)
Table 41. China Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 42. China Drugs for Osteoarthritis Pain Market Share by Type (2015-2020)
Table 43. China Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 44. China Drugs for Osteoarthritis Pain Market Share by Application (2015-2020)
Table 45. China Drugs for Osteoarthritis Pain Market Size by Region (US$ Million) (2015-2020)
Table 46. China Drugs for Osteoarthritis Pain Market Share by Region (2015-2020)
Table 47. Japan Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Drugs for Osteoarthritis Pain Market Share by Type (2015-2020)
Table 49. Japan Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Drugs for Osteoarthritis Pain Market Share by Application (2015-2020)
Table 51. Japan Drugs for Osteoarthritis Pain Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Drugs for Osteoarthritis Pain Market Share by Country (2015-2020)
Table 53. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Type (2015-2020)
Table 55. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Application (2015-2020)
Table 57. Southeast Asia Drugs for Osteoarthritis Pain Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Drugs for Osteoarthritis Pain Market Share by Country (2015-2020)
Table 59. Pfizer Company Details
Table 60. Pfizer Business Overview
Table 61. Pfizer Product
Table 62. Pfizer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 63. Pfizer Recent Development
Table 64. Johnson & Johnson Company Details
Table 65. Johnson & Johnson Business Overview
Table 66. Johnson & Johnson Product
Table 67. Johnson & Johnson Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 68. Johnson & Johnson Recent Development
Table 69. GlaxoSmithKline Company Details
Table 70. GlaxoSmithKline Business Overview
Table 71. GlaxoSmithKline Product
Table 72. GlaxoSmithKline Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 73. GlaxoSmithKline Recent Development
Table 74. Bayer Company Details
Table 75. Bayer Business Overview
Table 76. Bayer Product
Table 77. Bayer Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 78. Bayer Recent Development
Table 79. Eli Lilly Company Details
Table 80. Eli Lilly Business Overview
Table 81. Eli Lilly Product
Table 82. Eli Lilly Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 83. Eli Lilly Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 88. Novartis Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Product
Table 92. Sanofi Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Horizon Pharma Business Overview
Table 95. Horizon Pharma Product
Table 96. Horizon Pharma Company Details
Table 97. Horizon Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 98. Horizon Pharma Recent Development
Table 99. Abbott Company Details
Table 100. Abbott Business Overview
Table 101. Abbott Product
Table 102. Abbott Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 103. Abbott Recent Development
Table 104. Mylan Company Details
Table 105. Mylan Business Overview
Table 106. Mylan Product
Table 107. Mylan Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 108. Mylan Recent Development
Table 109. Daiichi Sankyo Company Details
Table 110. Daiichi Sankyo Business Overview
Table 111. Daiichi Sankyo Product
Table 112. Daiichi Sankyo Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 113. Daiichi Sankyo Recent Development
Table 114. TEVA Company Details
Table 115. TEVA Business Overview
Table 116. TEVA Product
Table 117. TEVA Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 118. TEVA Recent Development
Table 119. Almatica Pharma Company Details
Table 120. Almatica Pharma Business Overview
Table 121. Almatica Pharma Product
Table 122. Almatica Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 123. Almatica Pharma Recent Development
Table 124. Astellas Pharma Company Details
Table 125. Astellas Pharma Business Overview
Table 126. Astellas Pharma Product
Table 127. Astellas Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 128. Astellas Pharma Recent Development
Table 129. Tide Pharmaceutical Company Details
Table 130. Tide Pharmaceutical Business Overview
Table 131. Tide Pharmaceutical Product
Table 132. Tide Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 133. Tide Pharmaceutical Recent Development
Table 134. Iroko Pharmaceuticals Company Details
Table 135. Iroko Pharmaceuticals Business Overview
Table 136. Iroko Pharmaceuticals Product
Table 137. Iroko Pharmaceuticals Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 138. Iroko Pharmaceuticals Recent Development
Table 139. Hengrui Pharmaceutical Company Details
Table 140. Hengrui Pharmaceutical Business Overview
Table 141. Hengrui Pharmaceutical Product
Table 142. Hengrui Pharmaceutical Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 143. Hengrui Pharmaceutical Recent Development
Table 144. Abiogen Pharma Company Details
Table 145. Abiogen Pharma Business Overview
Table 146. Abiogen Pharma Product
Table 147. Abiogen Pharma Revenue in Drugs for Osteoarthritis Pain Business (2015-2020) (US$ Million)
Table 148. Abiogen Pharma Recent Development
Table 149. Research Programs/Design for This Report
Table 150. Key Data Information from Secondary Sources
Table 151. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drugs for Osteoarthritis Pain Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. External Features
Figure 5. Global Drugs for Osteoarthritis Pain Market Share by Application: 2020 VS 2026
Figure 6. Medical Care Case Studies
Figure 7. Personal Care Case Studies
Figure 8. Drugs for Osteoarthritis Pain Report Years Considered
Figure 9. Global Drugs for Osteoarthritis Pain Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global Drugs for Osteoarthritis Pain Market Share by Regions: 2020 VS 2026
Figure 11. Global Drugs for Osteoarthritis Pain Market Share by Regions (2021-2026)
Figure 12. Global Drugs for Osteoarthritis Pain Market Share by Players in 2019
Figure 13. Global Top Drugs for Osteoarthritis Pain Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drugs for Osteoarthritis Pain as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Drugs for Osteoarthritis Pain Revenue in 2019
Figure 15. North America Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa Drugs for Osteoarthritis Pain Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Pfizer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 43. Johnson & Johnson Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 44. GlaxoSmithKline Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 45. Bayer Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 46. Eli Lilly Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 47. Novartis Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 48. Sanofi Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 49. Horizon Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 50. Abbott Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 51. Mylan Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 52. Daiichi Sankyo Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 53. TEVA Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 54. Almatica Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 55. Astellas Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 56. Tide Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 57. Iroko Pharmaceuticals Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 58. Hengrui Pharmaceutical Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 59. Abiogen Pharma Revenue Growth Rate in Drugs for Osteoarthritis Pain Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
神経因性疼痛治療薬の世界市場（～2026年） Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia). In terms of value, North America is a large market and is expected to…- 変形性関節症治療の世界市場（～2026年） Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swellin…
- 痛み・発熱緩和薬の世界市場（～2026年） The demand for Pain and Fever Relief Drugs will continue to grow in the next few years. Market Analysis and Insights: Global Pain and Fever Relief Drugs Market The global Pain and Fever Relief Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of X…
- 動物疼痛管理薬の世界市場（～2026年） Market Analysis and Insights: Global Veterinary Pain Management Drugs Market The global Veterinary Pain Management Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Veterinary Pain Management Drugs Scope and Market…
- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…